T ype I IFNs are cytokines that are rapidly produced in response to viral infections and act as critical mediators of host antiviral responses. IFNs activate numerous genes with such roles as growth inhibition and apoptosis. Additionally, IFNs activate the innate and adaptive immune systems through mechanisms such as promoting maturation of APCs and activating various activities of CD8 ϩ T cells, B cells, and NK cells (1) . Type I IFNs include IFN-␤ and multiple IFN-␣ species, which are transcriptionally controlled by the transcription factors IFN regulatory factor (IRF) 3 3 and IRF7, in cooperation with NF-B and AP-1 (2) . IRF3 is constitutively expressed, whereas IRF7 is expressed at low levels in most cell types, but is up-regulated in response to IFN signaling. In unstimulated cells, IRF3 and IRF7 reside in the cytoplasm, but in response to viral infection, they become activated by phosphorylation by virally activated kinases, including TANK-binding kinase-1 (TBK1/T2K/NAK) or the inducible IB kinase (IKK-i/IB kinase ) (2-7). Phosphorylation allows the IRF to dimerize, translocate into the nucleus, and bind to IFN stimulatory response elements in the promoters of the IFNs and other target genes (8, 9) . Both IRF3 and IRF7 have been shown to have essential roles in regulation of IFN-␤, whereas IRF7 is the preferential regulator of the IFN-␣ genes (10, 11) . Once released from the cell, the IFNs bind to the type I IFN ␣/␤ receptor (IFNAR), activating the JAK-STAT signaling pathway. This activates the IFN-stimulated gene factor-3 transcription factor complex, consisting of IRF9, STAT1, and STAT2, which induces a large set of target genes important in antiviral responses, including IRF7, which acts to further enhance production of the IFN-␣ family (12, 13) . Thus, magnification of the antiviral IFN response leads to high localized and systemic IFN levels for global protection from viral invasion.
In recent years, much progress has been made in understanding how the host detects viral infections and activates IFN production. Several members of the TLR family of transmembrane receptors were the first class of innate host pattern recognition receptors found to recognize viral ligands and activate production of IFNs. TLR3 recognizes viral dsRNA or the dsRNA mimic polyinosinic acid:cytidylic acid (14) . TLR4 recognizes bacterial LPS and viral components, such as the respiratory syncytial virus F protein and the murine mammary tumor virus and Moloney murine leukemia virus envelope proteins (15, 16) . TLR3 and TLR4 are unique among TLRs in their ability to signal through the intracellular adaptor Toll/IL-1R domain-containing adaptor inducing IFN-␤ (TRIF) to activate IFN responses (17) (18) (19) (20) (21) (22) . TRIF activates IFN production through a signaling pathway dependent on TNFR-associated factor-3 (TRAF3), TBK1, and IRF3 (6, 7, (21) (22) (23) (24) (25) (26) . In plasmacytoid dendritic cells (pDC), however, viral detection by TLR7 and TLR9 activates a unique pathway for IFN-␣ production via the adaptor molecule MyD88 (27, 28) . The viral ligand for TLR7 is ssRNA species, whereas TLR9 recognizes CpG-DNA ϩ/ϩ TNFR1 Ϫ/Ϫ and TBK1 Ϫ/Ϫ TNFR1 Ϫ/Ϫ BMMs were infected with the indicated virus at a MOI of 1-3. At the indicated times, total RNA was extracted, and expression of IFN-␤, IFN-␣5, IP-10, and Mx1 was analyzed by Q-PCR (A, D, and G), or IFN-␣ and IFN-␤ levels in supernatants were quantitated by ELISA 24 h after infection (B, E, and H). Asterisks indicate IFN levels were undetectable by ELISA. Twenty-four hours after infection or treatment with medium alone, CD86 expression was measured by flow cytometry, and mean fluorescence intensity of the infected sample is indicated (C, F, and I). Results shown are representative of at least two independent experiments. motifs present abundantly in bacterial and viral pathogen genomes (29 -32) . IRF7 is highly expressed in pDC, and in response to TLR7 or TLR9 stimulation, is directly activated by the MyD88-dependent pathway that signals through TRAF3, TRAF6, osteopontin, and the kinases IRAK1 and IB kinase ␣, which have both been demonstrated to have the ability to phosphorylate IRF7 (10, (25) (26) (27) (28) (33) (34) (35) .
Alternative mechanisms exist for infected host cells to detect cytoplasmic viral nucleic acids. The cytosolic retinoic acid inducible gene-I (RIG-I)-like receptors (RLR), which include RIG-I and melanoma differentiation-associated gene-5, are RNA helicases that sense intracellular dsRNA of various RNA viruses (36 -39) . RLRs activate IFN responses through a complex involving IFN-␤ promoter stimulator-1 (IPS-1/MAVS/CARDIF/VISA) and TRAF3 (40 -47) . Sendai virus infection has been shown to activate IFN production in a RIG-I-dependent manner in macrophages and fibroblasts (38) . Examination of the role for TBK1 and IKK-i in Sendai virus-mediated IFN activation revealed a cell type-dependent requirement for these kinases based on their basal expression levels (7). Fibroblasts express low basal levels of IKK-i, and were strongly dependent on TBK1 for IFN responses, although IKK-i played a role in late induction presumably following its transcriptional up-regulation, because TBK1 Ϫ/Ϫ IKK-i Ϫ/Ϫ fibroblasts were completely deficient in IFN responses (6, 7, 48) . However, in macrophages, IKK-i is basally expressed much higher, and appears to play a primary role in RIG-I-mediated IFN activation because a TBK1 deficiency did not produce any significant defects, whereas TBK1/IKK-i double-knockout macrophages were completely defective in RIG-I pathway-induced IFN responses (7, 48 ).
An additional pathway has been discovered for the detection of intracellular DNA, particularly B-DNA, which relies on IRF3 to induce IFN responses (49 -52) . DNA-dependent activator of IFNregulatory factors (DAI/DLM-1/ZBP1) has been identified as an intracellular DNA receptor, although other unidentified DNA sensors most likely exist because studies in DAI-knockout cells failed to identify a phenotype (49, 53, 54) . Other signaling molecules with a potential role in this pathway include RIG-I and IFN-␤ promoter stimulator-1 in humans, but not mice (40, 47, 50, 55) . Analysis of DNA transfection into fibroblasts again revealed a role for both TBK1 and IKK-i because TBK1 Ϫ/Ϫ IKK-i Ϫ/Ϫ fibroblasts were completely unable to elicit IFN responses (50) . However, examination of the specific roles for TBK1 vs IKK-i have not yet been done in cells such as macrophages, which express high basal IKK-i levels. Thus, whether TBK1 and IKK-i play redundant or complementary roles in IFN induction by intracellular DNA sensing pathways remains unknown.
In this study, we used cells and mice lacking TBK1 to determine the relative contribution of TBK1 to IFN responses during DNA virus infections in vitro and in vivo. We demonstrate that unlike the RLR system, in which TBK1 and IKK-i appear to play overlapping roles in IFN induction, timely IFN responses to DNA virus infection or B-DNA transfection of macrophages were highly dependent on TBK1. Furthermore, when TBK1 Ϫ/Ϫ IKK-i Ϫ/Ϫ fibroblasts were reconstituted with equivalent levels of TBK1 or IKK-i, TBK1 rescued IFN responses to transfected B-DNA to a much stronger degree than IKK-i, indicating a functional difference either in mechanism or efficiency of these kinases in IRF3 activation. RLR and intracellular DNA virus detection pathways converged at IRF3 because IRF3 Ϫ/Ϫ macrophages were deficient in IFN responses to both RNA and DNA viruses. TBK1-dependent intracellular DNA virus detection pathways were dominant for macrophage activation of IFN responses, whereas the TLR9/ MyD88-dependent, TBK1-independent DNA virus detection pathways were dominant in pDC. Furthermore, we demonstrate that in vivo, following an intranasal infection with the murine ␥-herpesvirus-68 (MHV-68), TBK1 and IRF3 are required for optimal antiviral immunity and viral clearance. This study is the first to analyze the role of TBK1 in antiviral responses in vivo.
Materials and Methods

Mice and cells
TBK1
Ϫ/Ϫ TNFR1 Ϫ/Ϫ mice were a gift from W. Yeh (University of Toronto, Ontario, Canada). MyD88
Ϫ/Ϫ and TLR9 Ϫ/Ϫ mice were provided by S. Akira (Osaka University, Osaka, Japan). IRF3
Ϫ/Ϫ mice were a gift from T. Taniguchi (University of Tokyo, Tokyo, Japan). TRIF lps2/lps2 mice were provided by B. Beutler (Scripps Research Institute, La Jolla, CA). All mice were maintained and bred under specific pathogen-free conditions in the University of California, Department of Laboratory Animal Medicine mouse facility, and experiments were conducted within the parameters of our approved protocol. Bone marrow-derived macrophages (BMMs) were ϩ/ϩ TNFR1 Ϫ/Ϫ and TBK1 Ϫ/Ϫ TNFR1 Ϫ/Ϫ BMMs were transfected with 1 g/ml B-DNA (poly(dA-dT:dT-dA)) or stimulated with 10 ng/ml LPS. At the indicated times, total RNA was extracted, and expression of IFN-␤, IFN-␣5, IP-10, and Mx1 was analyzed by Q-PCR (A and B), or IFN-␣ and IFN-␤ levels in supernatants were quantitated by ELISA 24 h after stimulation (C and D). Asterisks indicate IFN levels were undetectable by ELISA. Twenty-four hours after stimulation or treatment with medium alone, CD86 expression was measured by flow cytometry, and mean fluorescence intensity of the stimulated sample is indicated (E and F). Results shown are representative of at least two independent experiments. differentiated from marrow from 6-to 10-wk-old mice, as previously described (56) . Briefly, bone marrow cells were harvested from mice and allowed to differentiate for 7-8 days in 2% L929-conditioned medium before assays were done. pDC were differentiated by culturing bone marrow cells with Flt3 ligand, as previously described (25) .
Viruses and reagents
BMMs were stimulated with LPS (Sigma-Aldrich) at 10 ng/ml. B-DNA (poly(dA-dT:dT-dA); Amersham Biosciences) was transfected into cells at 1 g/ml at a 1 g of DNA:1 l of Lipofectamine 2000 (Invitrogen) ratio. Flt3 ligand-derived dendritic cells (DC) were stimulated with CpG D19 (ggTGCATCGATGCAgggggG, in which uppercase and lowercase letters indicate bases with phosphodiester and phosphorothioate-modified backbones, respectively) (25) .
Sendai virus (Z strain) was cultured in 10-day-old chicken eggs. HSV-1 (strain 17) and MHV-68 (strain WUMS) were grown by culturing in vero cells. MHV-68 virus expressing luciferase under an M3 promoter (M3FL) was produced using a two-step allelic exchange with MHV-68 BAC as the target (57) (58) (59) . A cassette containing a viral M3 promoter-driven firefly luciferase was inserted between viral tRNA-1 and -2 (between genomic coordinate 746 and 747 of MHV-68 WUMS (U97553)) (59, 60) . The consequent mutation was confirmed by DNA sequencing, and the genomic integrity of mutated BAC MHV-68 was investigated by restriction enzyme digestion and Southern blot analysis, as previously described (57, 59) . Cells were infected with viruses at a multiplicity of infection (MOI) of 1-3 for the time points indicated.
In vitro assays
Cell lysates were fractionated into nuclear and cytoplasmic fractions, as described (18) . Cell lysates run on SDS-PAGE gels were probed with Abs against phosphorylated STAT1 (pY701; Cell Signaling Technology), STAT1, upstream transcription factor-2, and hemagglutinin (HA; Santa Cruz Biotechnology).
RNA was isolated using TRIzol (Invitrogen), and cDNA was synthesized using iScript (Bio-Rad), according to the manufacturer's instructions. Quantitative real-time PCR (Q-PCR) analysis was performed using the iCycler thermocycler (Bio-Rad), as previously described (18) . Primer sequences for IFN-␤, IFN-␣5, IFN-␥-inducible protein-10 (IP-10), Mx1, ISG-15, and ␤-actin have been described (7, 18) . All gene expression data presented were normalized to ␤-actin levels for each sample, and fold expression was determined as relative to medium-treated wild-type (WT) samples.
For ELISA, cells were cultured for 24 h with indicated stimuli before supernatants were harvested. IFN-␤ levels were measured using a kit (Pestka Biomedical Laboratories). IFN-␣ levels were measured using a rat anti-murine IFN-␣ as a coating Ab and a rabbit anti-murine IFN-␣ as a detection Ab (Pestka Biomedical Laboratories).
For flow cytometry analysis, BMMs were cultured with medium or the indicated virus or stimulus for 24 h. Cells were stained with PE-labeled Abs against CD86 or isotype control Abs, and mean fluorescence intensity was determined using flow cytometry.
Vectors and reconstituted cell lines
TBK1
Ϫ/Ϫ IKK-i Ϫ/Ϫ murine embryonic fibroblasts (MEFs) were provided by S. Akira. TBK1 and IKK-i were cloned into the pEBB eukaryotic expression vector containing a puromycin-resistant gene. Vectors were transfected into TBK1 Ϫ/Ϫ IKK-i Ϫ/Ϫ MEFs, and stably expressing cell lines were selected in the presence of 2.5 g/ml puromycin.
In vivo mouse infections and imaging
Mice were first anesthetized by i.p. injection with 200 mg/kg ketamine and 4 mg/kg xylazine in PBS. A total of 5000 PFU of M3FL in 20 l of DMEM was administered into the right nostril. On days 5 and 7 following infection, mice were imaged using the in vivo imaging system (IVIS; Xenogen). Briefly, mice were anesthetized by i.p. injection with 200 mg/kg ketamine, 4 mg/kg xylazine in PBS, followed by i.p. injection of 3 mg of D-luciferin/ mouse before imaging. Grayscale photographs and color images of imaged mice were superimposed with LivingImage (Xenogen) and Igor (WaveMetrics) programs, similar to that previously described (61) . The maximum photon flux value was measured for each mouse and expressed as photons/ s/cm 2 /steradian. On day 7 following imaging analysis, mice were euthanized and lungs were extracted and homogenized in PBS. Lung tissue homogenates were used to determine viral load by standard plaque assays, or luciferase values were quantified on a luminometer using a luciferase assay system kit (Promega). Statistical analyses were done using the MannWhitney U test.
Results
Activation of IFNs in response to DNA virus infections requires TBK1
The virus-induced type I IFN response involves activation of IRF3 and transcriptional up-regulation of a subset of primary response genes, including IFN-␤. Subsequently, autocrine and paracrine activity of type I IFNs activates the JAK-STAT pathway and upregulates a subset of secondary response genes. To examine the role of TBK1 in virus-induced activation of the type I IFN response, induction of IFNs and IFN-regulated genes was compared in TBK1
ϩ/ϩ and TBK1 Ϫ/Ϫ BMMs at various time points after viral infection. Transcription of IFN-␤, IFN-␣, and IFN-regulated genes such as IP-10 and Mx1 in BMMs infected with the DNA viruses HSV-1 or MHV-68 required TBK1 (Fig. 1, A and D) . This translated into a requirement for TBK1 for protein level expression of IFN-␤ and IFN-␣ in response to DNA viruses (Fig. 1, B and E) . Notably, infection with MHV-68 did not significantly up-regulate IFN-␣ expression as measured by either Q-PCR or ELISA (Fig. 1,  D and E) . However, induction of IFNs and IFN-regulated genes at both RNA and protein levels in BMMs infected with the RNA virus Sendai virus proceeded normally in the absence of TBK1 (Fig. 1, G and H) (7, 48) . IFNs have been shown to play critical roles in maturation of APCs by up-regulating expression of MHC and costimulatory molecules such as CD86 (23) . Thus, the mean fluorescence intensity of CD86 surface expression was examined in TBK1
ϩ/ϩ and TBK1 Ϫ/Ϫ BMMs 24 h after viral infections and compared with stimulation with medium alone. TBK1 was required for up-regulation of CD86 expression during infection with the DNA viruses HSV-1 and MHV-68 (Fig. 1, C and F) . However, up-regulation of surface expression of CD86 in response to Sendai virus did not require TBK1 (Fig. 1I) . Thus, in macrophages, TBK1 is required for timely induction of IFNs and IFN-mediated responses during DNA virus, but not RNA virus infections.
Activation of the IFN program by B-DNA requires TBK1
B-DNA and DNA from various sources including DNA viruses have been shown to induce IFN responses when introduced into the cytoplasm of cells (50, 51) . However, it is not yet known whether innate sensing of DNA viruses and B-DNA proceeds ϩ/ϩ and TBK1 Ϫ/Ϫ BMMs. We found that TBK1 was required for induction of IFNs and IFNregulated genes at the RNA and protein levels following transfection with B-DNA (Fig. 2, A and C) . TLR4 stimulation with LPS induces type I IFN responses (17, 18) . TLR4-mediated activation of IFN gene expression programs was highly dependent on TBK1 (Fig. 2, B and D) (6, 7) . TBK1 was also required for up-regulation of surface expression of CD86 in response to B-DNA transfection (Fig.  2E) . Stimulation of TLR4 with LPS also required TBK1 for up-regulation of CD86 expression (Fig. 2F) . Thus, similarly to that seen for DNA virus infections, TBK1 is required for induction of IFN responses to intracellular B-DNA, as well as TLR4 stimulation.
Activation of IFN-regulated signaling pathways by DNA viruses and B-DNA requires TBK1
Following production and release from the cell, IFNs bind and activate IFNAR. Activated JAKs phosphorylate STAT1, allowing formation of the IFN-stimulated gene factor-3 transcription factor complex that regulates expression of IFN response genes. In the absence of TBK1, STAT1 phosphorylation was greatly abrogated in response to B-DNA (Fig. 3A) . Additionally, during infection with the DNA viruses HSV-1 and MHV-68, TBK1 was required for optimal STAT1 phosphorylation (Fig. 3, B and C) . In contrast, Sendai virus-induced STAT1 phosphorylation did not require TBK1 (Fig. 3D) (7) . Thus, analysis of downstream signaling responses such as STAT1 phosphorylation further confirms the observation that TBK1 is required for timely induction of IFN responses during DNA transfection or infection with DNA viruses, but not RNA viruses.
TBK1 and IKK-i mediate distinct functions in IFN responses to DNA viruses
We have previously shown that reconstitution of TBK1 Ϫ/Ϫ MEFs with either TBK1 or IKK-i rescues IFN production and downstream signaling responses during Sendai virus infection (7) . To support our hypothesis that the role for IKK-i in IFN responses induced during DNA virus infections is different from the overlapping role it plays with TBK1 in the RIG-I signaling pathway, TBK1
IKK-i
Ϫ/Ϫ fibroblasts were stably reconstituted with vectors expressing either HA-tagged TBK1 or IKK-i. When TBK1 and IKK-i were expressed at equivalent levels in TBK1 Ϫ/Ϫ
Ϫ/Ϫ fibroblasts, TBK1 rescued STAT1 phosphorylation to a much stronger degree than IKK-i in response to DNA transfection (Fig. 3E) . Thus, there exists a functional difference either in mechanism or efficiency between TBK1 and IKK-i in activation of IFN responses by intracellular DNA detection pathways.
Activation of IFN programs in macrophages by DNA and RNA viruses is MyD88 independent, but IRF3 dependent
Previous studies have shown that DNA and RNA viruses can be recognized by TLR9 or TLR7, respectively, which elicits IFN-␣ production in pDC via MyD88-dependent pathways. To address the role of TLR9 and TLR7 pathways in virus-mediated IFN induction in macrophages, MyD88
Ϫ/Ϫ BMMs were infected with MHV-68 or Sendai virus, and analyzed for IFN responses. Induction of IFN gene programs and STAT1 phosphorylation did not require MyD88 in response to infection with either DNA (Fig. 4, A-D, and Supplementary Fig. S1A ). 4 Up-regulation of CD86 surface expression in response to MHV-68 was also MyD88 independent (supplemental Fig.  S1B ). 4 Additionally, TLR9 Ϫ/Ϫ , MyD88 Ϫ/Ϫ , and TRIF
Ϫ/Ϫ
BMMs infected with HSV-1 all induced normal STAT1 phosphorylation (supplemental Fig. S1C ). 4 Conversely, TBK1 was dispensable for IFN-␣ production in response to DNA virus infections or stimulation with CpG in pDC (supplemental Fig.  S1D ). 4 MyD88, however, was required for IFN-␣ production in pDC infected with DNA viruses (Supplementary Fig. S1E ). 4 Because TBK1 is differentially required for IFN responses to DNA and RNA viruses in macrophages, we examined the role for the downstream transcription factor IRF3 in BMM responses to MHV-68 and Sendai virus. IRF3 Ϫ/Ϫ BMMs had significantly reduced expression of IFNs and IFN-regulated genes during infection with both MHV-68 and Sendai virus (Fig. 4, E and F) . Furthermore, delayed STAT1 phosphorylation was observed in IRF3 Ϫ/Ϫ BMMs during infection with either MHV-68 or Sendai virus (Fig. 4, G and H) . Thus, despite the differential usage of TBK1, signals from intracellular sensors of both DNA and RNA viruses require IRF3 for optimal IFN induction in macrophages.
Collectively, these data show that production of IFNs in response to DNA viruses uses a TBK-IRF3-dependent pathway in macrophages, but proceeds through the TLR9-MyD88 pathway in pDC.
Resistance to pulmonary MHV-68 infection requires IRF3 and TBK1
MHV-68 has been used as a mouse model for Kaposi's sarcomaassociated herpes virus and EBV infections. MHV-68 naturally infects the host most likely through the respiratory tract and establishes an acute infection in the lungs, followed by long-term latency in splenic B cells, lung epithelial cells, DC, and macrophages (62, 63) . Although MHV-68 infection does not result in high systemic IFN levels, the IFN system is crucial for control of the viral infection because IFNAR Ϫ/Ϫ mice are more susceptible to infection (64, 65, 75) . Previous studies have indicated that pDC are the major IFN-producing cell type during in vivo infections with DNA viruses via the TLR9-MyD88 pathways (66, 67) . However, we sought to determine the contribution of TBK1-IRF3-dependent pathways during DNA virus infections in vivo.
Bioluminescence imaging was used to monitor an active infection of mice with M3FL (59). Mice were visualized at 5 and 7 days postinfection, and the maximum luminescence values were quantified for each mouse. IRF3
Ϫ/Ϫ mice were more susceptible to 4 The online version of this article contains supplemental material. M3FL infection than WT mice, as evidenced by a statistically significant elevation of maximum luminescence values by ϳ1 logfold in IRF3 Ϫ/Ϫ mice on both days (Fig. 5) . Thus, IRF3 is required for optimal resistance to in vivo M3FL infections. Additionally, in TBK1 ϩ/ϩ mice, the infection remained confined to the nostril area with limited dissemination by day 7, whereas TBK1 Ϫ/Ϫ mice showed elevated viral spread to the lungs and salivary glands over time (Fig. 6, A and B) . A statistically significant elevation of maximum luminescence values by over 1 log-fold was seen on both days for TBK1 Ϫ/Ϫ mice as compared with TBK1 ϩ/ϩ mice (Fig. 6,  A and B) . At day 7 postinfection, whole lungs were extracted from infected mice, homogenized, and analyzed by luminometer and standard plaque assay for quantification of viral load. Both measurements confirmed that TBK1 Ϫ/Ϫ mice had higher viral titers by ϳ1 log-fold in the lungs than TBK1 ϩ/ϩ mice (Fig. 6, C and D) . Thus, these studies show an indispensable role for the classical IRF3-TBK1 pathway in regulating in vivo immune resistance mechanisms during DNA virus infections.
Discussion
Production of type I IFN is characteristic of virally infected cells and is vital to the host immune defense against viral infection. Multiple families of pattern recognition receptors, including TLRs, RLRs, DAI, and other DNA sensors, exist to recognize viral infections and activate IFN responses. As the pathways involved in type I IFN production are being carefully studied, the responsible signaling mediators during DNA virus infections in different cell types remain an open question. In this study, we identify a critical requirement for TBK1 in activation of the IFN response to DNA viruses in macrophages. Moreover, we demonstrate the in vivo requirement for the TBK1-IRF3 pathway in immune resistance to infection with the DNA virus MHV-68.
We and others have previously observed that the pathways leading to IFN activation during virus infections use different signaling molecules in various cell types. RIG-I mediates the activation of IFN responses to Sendai virus in conventional DC and fibroblasts (38) . In the RIG-I pathway, TBK1 and IKK-i appear to play redundant functions in IRF3 activation. During Sendai virus infection, fibroblasts that express low levels of IKK-i rely heavily on TBK1 for IRF3 activation (6, 7) . However, macrophages express relatively high levels of IKK-i, and thus, activation of IRF3 can proceed normally in the absence of TBK1 (7, 48) . The roles for TBK1 and IKK-i in B-DNA-induced IFN responses have been studied in fibroblasts, and IKK-i has been theorized to play a redundant function with that of TBK1 (50) . However, the effect of a TBK1 deficiency during infection with DNA viruses had not yet been studied in macrophages or other cells highly expressing IKK-i.
In response to infection with the DNA viruses MHV-68 and HSV-1, BMMs derived from TBK1 Ϫ/Ϫ mice were found to be defective in their ability to up-regulate production of IFNs and activate IFN-regulated gene programs and downstream IFN-mediated signaling responses. Thus, although IKK-i is coexpressed in BMMs, TBK1 and IKK-i apparently play nonredundant roles in IFN induction in response to DNA viruses. Furthermore, TBK1 Ϫ/Ϫ
IKK-i
Ϫ/Ϫ cells were reconstituted with equivalent levels of TBK1 or IKK-i to compare their relative contributions to the type I IFN response to DNA recognition. Reconstitution with TBK1 rescued the IFN response to a much stronger degree than reconstitution with IKK-i when cells were transfected with B-DNA. Thus, these studies indicate that although TBK1 and IKK-i both contribute to IFN production (50), they differ either in mechanism or efficiency in activation of IFN responses to intracellular DNA virus detection pathways.
IRF3 has been shown to play a key role in the induction of IFN responses to RNA and DNA virus infections in this and other in vitro studies (Figs. 4 and 5) (10, 11, 68 -70) . However, the in vivo contribution of IRF3 during DNA virus infections appears to be dependent on route of infection because IRF3 was dispensable in induction of IFNs during i.v. HSV-1 infections, but important in vaginal HSV2 infections (10, 71) . In this study, we show that IRF3 was important for immunity to an intranasally introduced DNA virus, in which major IFN producers may be respiratory epithelial cells and alveolar macrophages. Thus, IRF3 is essential for DNA virus-mediated type I IFN responses in vitro and contributes to host immunity in vivo. Therefore, our studies are consistent with a model of DNA virus-induced IFN induction proceeding through a signaling pathway dependent on TBK1 and IRF3.
Previous studies have indicated that TLR9-independent detection of DNA viruses is due to intracellular recognition of viral DNA. Transfection of cells with various types of DNA, including B-DNA has been shown to elicit strong type I IFN responses (50, 51) . However, whether synthetic B-DNA and viral DNAs are recognized by the same sensors remains to be determined. Our study found that TBK1 was required for the IFN response in BMMs when transfected with B-DNA. Thus, TBK1 is a convergence point for induction of IFNs following intracellular recognition of B-DNA and DNA virus infections.
In lieu of the many viral detection pathways identified, it is clear that different pathways are dominant in specific cell types and tissues. The TLR9/MyD88 pathway is activated during infection with DNA viruses in pDC, resulting in production of high levels of IFN-␣ via direct activation of IRF7 (27, 28) . We demonstrate that induction of the type I IFNs by DNA viruses in BMMs is independent of TLR9 and MyD88 signaling pathways, whereas in pDC, IFN production requires MyD88, but not TBK1. Thus, the TBK1-IRF3 pathway clearly represents a DNA virus detection mechanism separate from the TLR9-MyD88 system. pDC have been demonstrated to be primary in vivo producers of IFN-␣ during infection with many viruses, via the TLR7/8 and TLR9 pathways. The role for different cell types and pathways in mediating in vivo antiviral responses has recently been demonstrated for RNA viruses. pDC were the strongest producers of IFNs during systemic Newcastle disease virus infection, although macrophages and conventional DC also contributed to IFN production (72) . However, during pulmonary RNA virus infections, alveolar macrophages were the major producers of IFN via RLRs (72) . The absence of either pDC or the TLR9-MyD88 axis was detrimental to host control of DNA virus infections such as HSV-2 and murine CMV in vivo (73, 74) . However, the contribution of intracellular DNA virus detection pathways to host immunity has yet to be explored during in vivo infections.
Using a luciferase-expressing MHV-68 variant to monitor active infections of mice (M3FL), we find that mice lacking TBK1 or IRF3 were more susceptible to intranasal MHV-68 infection. Although we were unable to detect IFN production in these mice, this indicates that even low levels of IFN production through TBK1-IRF3 pathways make important contributions to host immunity. Thus, whereas TLR9 detection of DNA viruses by pDC is likely to additionally contribute to IFN production and subsequent immune defense, detection of infections through TBK1-dependent pathways by other cell types such as alveolar macrophages and respiratory epithelial cells is essential for optimal host control of viral infections.
Viruses are diverse, and quickly evolving organisms and hosts have thus developed multiple mechanisms for detecting viral invasion and initiating IFN and immune responses. Although we have characterized the role for TBK1 pathways in response to DNA virus infections, future studies are needed to address the specific roles of TBK1 and IKK-i, as well as identify other signaling mediators and host receptors that contribute to DNA virus recognition. Because TBK1 is required for viral resistance in vivo, it would be interesting to determine the cell types that elicit IFN production via TBK1-pathways. Additionally, it would be interesting to determine the quality of IFN and immune responses initiated by TLR9-MyD88 vs TBK1-IRF3 pathways following virus infections by different routes. A clear understanding of these different pathways would contribute to better understanding how viruses are able to inhibit the IFN response and how we can in turn manipulate the host response to virus infections and other diseases in which IFNs contribute, such as autoimmune disorders and cancer.
